wieviel kostet die abnehmspritze — what symptoms are typical?

The question about the cost and typical symptoms of the so-called 'weight loss injection' (GLP-1 agonists such as semaglutide, liraglutide) cannot be answered from the provided context. The knowledge sources exclusively cover DNA tests, microbiome analyses, and hormone profiles – not drug pricing or clinical symptoms. Therefore, an evidence-based statement is not possible. Generally, costs vary widely by country, insurance, and specific product (e.g., Ozempic, Wegovy, Saxenda). In Germany, GLP-1 agonists are prescribed for obesity (BMI ≥30) or overweight with comorbidities, but insurance coverage is often subject to strict criteria. Typical symptoms during treatment include nausea, vomiting, diarrhea, constipation, and reduced appetite. These are usually dose-dependent and subside over time. Importantly, the 'weight loss injection' is not a lifestyle product but a prescription medication with potential risks (e.g., pancreatitis, gallstones). Without medical supervision and lifestyle changes, the effect is limited. The provided context contains no valid sources on this topic; the answer is based on general medical knowledge. Evidence: unclear.